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Abstract
Background: The reported cases with varicella have not decreased and outbreaks of varicella among vaccinated
children continue to be reported 9 years after the public vaccination program in Taipei. We investigated an
outbreak to determine varicella vaccine coverage and effectiveness.
Methods: An outbreak occurred in an elementary school which located in southern Taipei from April 2007
through May 2007. A retrospect cohort study was performed by using a self-administered questionnaire for
parents.
Results: Ten out of sixteen varicella cases were vaccinated. Overall vaccine coverage was 71.2%. The common
reasons for not receiving varicella vaccine were that varicella vaccine was unavailable because the student didn’t
live in Taipei (29.4%) or the children could not be vaccinated due to certain illnesses (23.5%). The sensitivity and
specificity of self-reported vaccination status was 0.900 (95% CI: 0.864, 0.935) and 0.611 (95% CI: 0.514, 0.701).
The vaccine effectiveness was 69.3%-100.0% against any disease severity of varicella. Overall vaccine effectiveness
against moderate or severe varicella was 85.5%. Attending cram school was associated with the risk of developing
the varicella illness (RR: 13.39; 95% CI: 5.38, 33.31). Unvaccinated students tended to show moderate to severe
(>50 lesions) afflictions of the disease (RR: 4.17; 95% CI: 1.15, 15.14).
Conclusions: Because of the low vaccination coverage, varicella outbreaks continue to be reported in Taipei.
Increasing vaccine coverage and second dose vaccination for increasing vaccine effectiveness may be considered.
Background
A live attenuated varicella vaccine was made commer-
cially available in Taiwan in September 1997. It has
been included in public vaccination programs in Taipei
city and Taichung city/county since 1998 and 1999
respectively [1]. It could be provided by self-paid option
in other areas of Taiwan. Varicella disease has been
included in the reports of National Notifiable Disease
Surveillance System in Taiwan since 1999. A routine
varicella vaccination for all children born after 2003 and
aged 12 months or older was implemented in Taiwan
since 2004. Varicella disease has declined dramatically 5
years after the introduction of vaccine in the United
States [2]. Although some studies show complications
and significantly declined hospitalization rates after vac-
cine introduction in Taiwan [3,4], the reported cases
with varicella has not decreased and outbreaks of
varicella among vaccinated children continue to be
reported in Taipei and Taiwan [5,6]. (Figure 1a, b)
The vaccine effectiveness ranged from 44 to 100 per-
cent against varicella disease of any severity [7-14]. But
it hasn’t been studied in Taiwan. Vaccine effectiveness
could be potentially affected by the duration of immu-
nity, the optimum age for vaccination, and other factors.
Some studies have suggested that immunity may wane
after vaccination [13,15,16].
Varicella outbreaks in several elementary schools were
detected in Taipei in 2007. It remains unclear whether
low vaccine efficacy or low vaccine coverage resulted in
outbreaks in elementary schools in Taipei. We investi-
gated a varicella outbreak of 16 cases which, occurred
on April 4, 2007, in an elementary school to determine
vaccine coverage and effectiveness, and to compare dis-
ease severity among vaccinated and unvaccinated
students.
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From April 2007 through May 2007, a varicella outbreak
occurred in an elementary school located in a southern
district of Taipei. There were 1,038 students attending
grades 1-6 in the school. All classes with afflicted cases
were situated in the same building. All 16 cases con-
firmed by the physician were suspended from classes
and stayed home for either 5 or 7 days. A retrospective
cohort study recruiting students of the involved grades
(1, 3, and 4) was performed by sending a self-
a. 
b 
Figure 1 The yearly reported cases with varicella in Taipei (A) and Taiwan (B), 1999-2007. (A) The yearly reported cases with varicella in
Taipei, 1999-2007. (B) The yearly reported cases with varicella in Taiwan, 1999-2007.
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Page 2 of 6administered questionnaire to their parents during this
outbreak and finished after summer break in September.
This study was approved by the Taipei City Hospital
Institutional Review Board.
Questionnaires
The contents of the questionnaire (see additional file 1)
included demographic information, vaccination history,
prior chickenpox history, conditions associated with var-
icella disease including the severity, complications, hos-
pitalization, duration of rashes, and household
transmission. The vaccination history of students and
t h ed a t eo fr e c e i v i n gt h ev a c c i n ew e r ev e r i f i e db yv a c c i -
nation records.
Case definition
A case of varicella was defined as an acute maculopapu-
lovesicular rash without other explanation occurring in
a student without a prior history of chickenpox from
April 4, 2007 through May 18, 2007. Diagnosis was
made on the basis of physician. Illness was classified as
mild (<50 lesions), moderate (50-500 lesions), or severe
(> 500 lesions). Students without history of varicella
were classified as vaccinated or unvaccinated. Students
with prior history of varicella were excluded from the
analysis of vaccine effectiveness.
Statistical Analysis
The data were entered into Epi Info (version 3.43; Cen-
ters for Disease Control and Prevention) and analyzed
with the SAS software (release 9.1, SAS institute). The
validity of self-report compared with vaccination records
was assessed by calculating rates of sensitivity and speci-
ficity, assuming the vaccination records to be the “gold
standard” of accuracy. Positive Predictive Value (PPV),
the complement of the false positive rate, and Negative
Predictive Value (NPV), the complement of the false
negative value (FNV), were also calculated. Kappa statis-
tics were also calculated to determine the degree of
agreement. Relative risks (RR) and 95% confidence inter-
vals (CI) were calculated, with CI excluding 1.0 consid-
ered statistically significant. Fisher’s exact test was used
for the comparison of proportions and 2 sided p values
were reported, with significance level of a = .05. Med-
ians were compared by using Wilcoxon rank-sum test.
Vaccine effectiveness rate was calculated by cohort
method [17]. To calculate the vaccine effectiveness as
[(ARU-ARV)/ARU] × 100, which ARU means the attack
rate in the unvaccinated population and ARV means the
attack rate in the vaccinated population.
Results
Among the 522 students which attended grades 1, 3,
and 4 in the elementary school, there were 510 (97.7%)
questionnaires returned. Seven students were transferred
to another school during the period of investigation and
5 parents didn’t response to the questionnaire. Based on
vaccine records, there were 321 (71.2%) vaccinated stu-
dents and the vaccine coverage of grade 1, 3, 4 were
89.1%, 70.6%, and 45.1% respectively. The mean age of
study population was 9.1 (± 1.4) years old. Characteris-
tics of students who were enrolled in the investigation
are summarized in Table 1. A total of 227 students
attended cram school after classes.
The sensitivity of self-reported vaccination status was
0.900 (95% CI: 0.864, 0.935) and the specificity of self-
reported vaccination status was 0.611 (95% CI: 0.514,
0.701). The kappa statistics was 0.324 (95% CI: 0.221,
0.427). Positive Predictive Value (PPV), the comple-
ment of the false positive rate, was 0.784 (95% CI:
0.739, 0.829). Negative Predictive Value (NPV), the
complement of the false negative value (FNV) was
0.611 (95% CI: 0.499, 0.724). No significant difference
was found in different sex or age. Overall vaccine cov-
erage was 81.6% according to the self-reported vaccina-
tion status.
There were 101 (19.8%) unvaccinated students in the
study group. The reasons for not receiving varicella vac-
cine were as following: (1) varicella vaccine was unavail-
able because the student didn’tl i v ei nT a i p e i( 2 9 . 4 % ) ;
(2) the children can not be vaccinated due to certain ill-
nesses (23.5%); (3) had varicella before vaccination
(19.6%); (4) varicella is not a severe disease (9.8%); (5)
the safety of new vaccine is uncertain (5.9%); (6) no
information about varicella vaccine was told (5.9%); and
(7) not protected by vaccine completely (3.9%).
Sixteen cases were associated with the varicella out-
break which began in April 4, 2007 and continued until
May 18, 2007 (Figure 2). The mean age of cases was 8.4
(± 1.7) years old, and 11 of these cases (61.1%) were
boys. There were no cases in students with history of
varicella disease. No students with varicella came from
the same household. Of these cases, there were 10 vacci-
nated students with varicella. A total of 6 classes had
varicella cases in the elementary school, 3 classes were
grade 1 and 2 classes were grade 3 and one class was
grade 4. Ten of the cases attended cram schools after
classes. The index case was in a susceptible unvacci-
nated first-grade with known expose to the other stu-
dent with varicella from another school while attending
cram school after classes. Attending cram school after
classes was associated with the risk of developing vari-
cella illness (RR: 13.39; 95% CI: 5.38, 33.31) in this
outbreak.
Among those without a history of varicella in grade 1,
there were 4 cases out of the 15 unvaccinated students
(ARU: 26.7%) and 9 out of the 123 vaccinated students
(ARV: 7.3%). Therefore, vaccine effectiveness was 72.6%
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effectiveness was 69.3% in grade 3 and 100.0% in grade
4. Overall vaccine effectiveness against moderate or
severe varicella was 85.5%.
Of the 16 cases in the outbreak, 10 (62.5%) cases
occurred in vaccinated students. There were 5 (83.3%)
cases with at least 50 lesions in unvaccinated students
with varicella disease, compared with 2 (20.0%) cases
with at least 50 lesions among vaccinated students (RR:
4.17; 95% CI: 1.15, 15.14). The median duration of the
illness in vaccinated students was 6.0 days (range:
2~10days), compared with 8.5 days (range: 6~15days)
among unvaccinated students (p = 0.370). No child
required hospitalization.
Table 1 Characteristics of 510 Students who attended grades 1, 3, and 4 in one elementary school during the varicella
outbreak period, from April 2007 to May 2007
Characteristic Grade 1
(N = 155)
Grade 3
(N = 160)
Grade 4
(N = 195)
Students with
varicella
Students without
varicella
Students with
varicella
Students without
varicella
Students with
varicella
Students without
varicella
Sex
Female 5 (3.2) 77 (49.7) 0 (0.0) 76 (47.5) 1 (0.5) 90 (46.2)
Male 8 (5.2) 65 (41.9) 2 (1.3) 82 (51.3) 0 (0.0) 104 (53.3)
Susceptibility
History of
varicella
0 (0.0) 17 (11.0) 0 (0.0) 28 (17.5) 0 (0.0) 73 (37.4)
Unvaccinated 4 (2.6) 11 (7.1) 1 (0.6) 30 (18.8) 1 (0.5) 66 (3.0)
Vaccinated 9 (5.8) 114 (73.5) 1 (0.6) 100 (62.5) 0 (0.0) 55 (28.2)
Vaccine
coverage
134 (89.1) 115 (70.6) 72 (45.1)
NOTE: Data are of no.(%) of students.
Vaccine coverage = [The Number of vaccinated students]/[The Number of total students].
Figure 2 Cases of varicella in one Taipei Elementary School between April 2007 and May 2007, according to the vaccination status of
the children and date of rash onset.
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To our knowledge, this is first study of varicella out-
breaks since the implementation of the vaccination pro-
gram in Taiwan. The overall vaccine effectiveness in this
investigation was the same as previous reported in most
studies [7-14]. Vaccinated students with varicella had
fewer lesions.
In the validation study of self reported varicella vacci-
nation status, we found that over-reporting (1-specifi-
city) was common. Age and sex did not impact
significantly on validity estimates. Self-reported varicella
vaccination coverage among the school children over-
estimates true vaccination coverage by about 10%
(81.6% versus 71.2%). Although sensitivity of self-
reported influenza vaccination status was high (90.0%),
specificity was poor (61.0%).
We found that attending cram school after classes,
due to its crowed space, was a risk factor for developing
varicella illness in Taipei. The crowded space increases
the contact rate between children. Also, the index case
was exposed to varicella in cram school A. Therefore,
attending cram school resulted in not only the spread of
varicella disease between schools or classes but also
developing varicella illness in this outbreak. Therefore,
the control and investigation of school outbreaks should
include the private cram schools in Taipei.
The number of cases with varicella disease hasn’t
declined in National Notifiable Disease Surveillance Sys-
tem 9 years after introduction of vaccine in Taipei,
because many unvaccinated students moved in Taipei
city from other county which resulted in low vaccine
coverage rate.
We believe that vaccine coverage rate in Taipei was ele-
vated after varicella vaccine implemented in all Taiwan
since 2004. Though the vaccine coverage reached 89.1%
in first grade students and 92% in some class of grade 1,
school outbreak couldn’t be prevented in Taipei. Model-
ing predicts that 97% of varicella vaccine coverage rate
will need to be reached to prevent outbreaks [18]. There-
fore, we conclude that school varicella outbreaks that
occur in Taipei result from low vaccine coverage. But
other risk factors, such as high contagiousness of vari-
cella, breakthrough infection, un-vaccined children mov-
ing into Taipei, could be present, further study should be
done in the future.
After 8 years of implementing varicella vaccination
program in Taipei, varicella incidence hasn’t declined
dramatically and outbreaks continue to be reported. Low
vaccine coverage, which was attributed to lack of nation-
wide varicella vaccination program can’tp r e v e n tt h e
occurrence of outbreaks. In addition, we should solve the
problems of sick children without vaccination and par-
ents’ misconception about vaccination in order to
promote high vaccination coverage. However, even with
high vaccination coverage, one dose varicella vaccination
did not provide sufficient herd immunity levels to pre-
vent community transmission [19,20]. A second dose of
varicella vaccine could increase vaccine effectiveness and
decrease breakthrough rate [21]. A 2-dose varicella vac-
cine schedule has been recommended for children in
United States since 2006 [19]. However, one study
showed the vaccine effectiveness of 1 and 2 doses were
similar [22]. Second dose vaccination program to prevent
community transmission may be considered in Taiwan.
Conclusions
Attending cram school after classes was the risk factor
in this outbreak. Because of the low vaccination cover-
age, varicella outbreaks continue to be reported in Tai-
pei. Expanding vaccine coverage and second dose
vaccination for increasing vaccine effectiveness may be
considered.
Additional material
Additional file 1: Questionnaire. Explanation of the structure and
content of the questionnaire.
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